CSF VIRUS IDENTIFIED

CSF VIRUS IDENTIFIED was reported 70 times

CSF VIRUS IDENTIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Benzothiazole [EPC] 1 0.0004
1 CCR5 Co-receptor Antagonist [EPC] 1 0.0004
2 Rifamycin Antimycobacterial [EPC] 1 0.0003
3 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 27 0.0002
4 Cytochrome P450 3A Inhibitor [EPC] 12 0.0002
5 Protease Inhibitor [EPC] 8 0.0002
6 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
7 Calcineurin Inhibitor Immunosuppressant [EPC] 7 0.0001
8 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
9 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
10 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
11 Macrolide Antimicrobial [EPC] 1 0.0000
12 Aromatase Inhibitor [EPC] 2 0.0000
13 Alkylating Drug [EPC] 4 0.0000
14 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
15 Topoisomerase Inhibitor [EPC] 1 0.0000
16 Integrin Receptor Antagonist [EPC] 1 0.0000
17 alpha-Adrenergic Blocker [EPC] 1 0.0000
18 Azole Antifungal [EPC] 1 0.0000
19 Janus Kinase Inhibitor [EPC] 1 0.0000
20 Interferon beta [EPC] 1 0.0000
21 Proton Pump Inhibitor [EPC] 3 0.0000
22 Retinoid [EPC] 1 0.0000
23 Corticosteroid [EPC] 5 0.0000
24 Platinum-based Drug [EPC] 1 0.0000
25 Kinase Inhibitor [EPC] 2 0.0000
26 beta-Adrenergic Blocker [EPC] 1 0.0000
27 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
28 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
29 Vitamin C [EPC] 1 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 1 0.0000